Potential Treatment of Breast and Lung Cancer Using Dicoma anomala, an African Medicinal Plant

Alexander Chota1, Blassan P George1, Heidi Abrahamse1

  • 1Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa.

Insights

This review highlights the anticancer potential of Dicoma anomala, a plant used in traditional African medicine. Research indicates its compounds may offer less toxic cancer treatment options by inducing cancer cell death.

Area of Science:

  • Phytomedicine
  • Cancer Research
  • Ethnobotany

Background:

  • Cancer is a leading global cause of death, often linked to carcinogen exposure.
  • Plant-derived compounds offer potentially less toxic alternatives to conventional cancer therapies.
  • Dicoma anomala, a Sub-Saharan African herb, is traditionally used for various ailments, including cancer.

Purpose of the Study:

  • To review the therapeutic benefits of Dicoma anomala.
  • To focus on its application in cancer treatment.
  • To explore the mechanisms of plant-derived anticancer agents in inducing cell death.

Main Methods:

  • Literature review of scientific studies on Dicoma anomala.
  • Analysis of ethnobotanical data regarding its traditional uses.
  • Examination of research on the phytochemical composition and bioactivity of Dicoma anomala.

Main Results:

  • Dicoma anomala contains various bioactive compounds with potential anticancer properties.
  • Traditional uses of Dicoma anomala for cancer treatment are supported by preliminary scientific evidence.
  • The plant's compounds may induce cancer cell death through specific molecular pathways.

Conclusions:

  • Dicoma anomala shows promise as a source of novel anticancer agents.
  • Further research is warranted to isolate and characterize active compounds and validate their efficacy and safety.
  • This plant represents a valuable resource for developing new, plant-based cancer therapies.